CJC-1295 mastery course
Unit 9 of 12

Product quality & regulation

CJC-1295 carries a safety issue most peptides do not: because the DAC and no-DAC versions differ in dose by roughly ten…

The label problem, and the legal reality

CJC-1295 carries a safety issue most peptides do not: because the DAC and no-DAC versions differ in dose by roughly tenfold, a mislabeled vial can expose someone to far more, or far less, than they intend. On top of that, CJC-1295 is not an approved medicine anywhere, and it is banned in sport.

This unit covers the two things a careful reader most needs: how to think about product identity and quality in an unregulated market, and exactly where CJC-1295 stands legally with the FDA and the anti-doping system. Both are about protecting yourself from confident claims that do not hold up.

Key terms

The tenfold label problem


How identity is actually confirmed


Where it stands legally


Banned in sport, on purpose


Reading a vendor critically